StonvexLoading…
StonvexStonvexStonvexCore line items from FCF's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $157.22M | $632.69M | $468.76M | $306.05M |
Operating Income | $47.23M | $191.36M | $134.92M | $83.10M |
Net Income | $37.55M | $152.30M | $107.43M | $66.10M |
EPS (Diluted) | $0.37 | $1.47 | $1.04 | $0.64 |
Total Assets | $12.26B | $12.34B | $12.31B | $12.24B |
Total Liabilities | $10.71B | $10.79B | $10.77B | $10.72B |
Cash & Equivalents | $342.94M | $180.36M | $161.41M | $160.17M |
Free Cash Flow OCF − CapEx | Not available | $171.45M | Not available | Not available |
Shares Outstanding | 101.68M | 102.84M | 104.29M | 104.93M |